Abiomed, a maker of the Impella heart pump, agreed to acquire Breethe, a developer of a novel extracorporeal membrane oxygenation system. Financial terms were not disclosed. “Abiomed is the best positioned company to build on the legacy of what we started. I am confident that the addition of Breethe’s technology into Abiomed’s product portfolio will further enhance Abiomed’s ability to improve outcomes for their patients and serve a new patient population,” Bartley Griffith, MD, Breethe Founder.